Figure 1
Figure 1. Discordance between referral diagnoses and final diagnoses at MDACC. (A) By French-American-British. RA indicates refractory anemia; RARS, refractory anemia with ring sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RCMD-RS, refractory cytopenia with multilineage dysplasia with ringed sideroblasts; CMML, chronic myelomonocytic leukemia; MDS-U, myelodysplastic syndrome unclassifiable; AML, acute myelogenous leukemia; others, chronic myeloid leukemia, myelofibrosis, normal bone marrow; and pts, patients. (B) By International Prognostic Scoring System (IPSS). Nonapplicable includes referral diagnosis of AML, chronic lymphocytic leukemia, CMML, myelofibrosis, or normal bone marrow examination. Pts indicates patients.

Discordance between referral diagnoses and final diagnoses at MDACC. (A) By French-American-British. RA indicates refractory anemia; RARS, refractory anemia with ring sideroblasts; RCMD, refractory cytopenia with multilineage dysplasia; RCMD-RS, refractory cytopenia with multilineage dysplasia with ringed sideroblasts; CMML, chronic myelomonocytic leukemia; MDS-U, myelodysplastic syndrome unclassifiable; AML, acute myelogenous leukemia; others, chronic myeloid leukemia, myelofibrosis, normal bone marrow; and pts, patients. (B) By International Prognostic Scoring System (IPSS). Nonapplicable includes referral diagnosis of AML, chronic lymphocytic leukemia, CMML, myelofibrosis, or normal bone marrow examination. Pts indicates patients.

Close Modal

or Create an Account

Close Modal
Close Modal